Growth hormone treatment adherence in prepubertal and pubertal children with different growth disorders.

Background/aims: Treatment of children with growth disorders with recombinant human growth hormone is necessary for improved outcomes, including final height.

Methods: Adherence data from the Observational Study Saizen®-online, recorded with the easypod™ device collected between October 2009 and May 2011, were analyzed in pediatric patients receiving recombinant human growth hormone treatment for a variety of growth disorders.

Results: Data from 75 children (46 boys, 29 girls) with different growth disorders were analyzed over a period of 343 ± 201 (SD) days.